ArticleFrontiers in oncology2026
Case Report: Malignant transformation of deep infiltrating endometriosis: a report of two cases and literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep infiltrating endometriosis (DIE) is a severe form of endometriosis that rarely undergoes malignant transformation, and when it does, diagnosis is often difficult. Here, we report two cases of long-standing DIE that progressed to endometrioid adenocarcinoma. The first case involved a 44-year-old woman with pelvic DIE complicated by hydronephrosis, who underwent radical surgery with ureteroneocystostomy. Postoperative pathology confirmed well-differentiated endometrioid adenocarcinoma, and she remained disease-free after receiving chemotherapy and targeted therapy. The second case was a 47-year-old woman with an 18-year history of dysmenorrhea and chronic pelvic pain, also complicated by hydronephrosis. Surgical exploration revealed extensive pelvic adhesions and DIE lesions, and pathology confirmed endometrioid adenocarcinoma. She received postoperative chemotherapy, including an antibody-drug conjugate, and showed no evidence of recurrence during follow-up. A review of the literature identified 57 additional reported cases of malignant transformation arising from DIE, most commonly involving the rectosigmoid colon, vagina, and ureter. Endometrioid adenocarcinoma was the most frequently observed histological subtype. Due to its nonspecific clinical manifestations and overlap with benign DIE, diagnosis remains challenging. Current evidence supports a multidisciplinary approach combining complete surgical resection with adjuvant therapy. Clinicians should remain aware of the rare but possible malignant potential of DIE to facilitate earlier diagnosis and appropriate management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.